On Monday Passage Bio Inc (NASDAQ: PASG) opened higher 20.90% from the last session, before settling in for the closing price of $0.33. Price fluctuations for PASG have ranged from $0.26 to $1.33 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -1.48%. Company’s average yearly earnings per share was noted 31.21% at the time writing. With a float of $53.21 million, this company’s outstanding shares have now reached $62.15 million.
Considering the fact that the conglomerate employs 60 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Passage Bio Inc (PASG) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Passage Bio Inc is 14.38%, while institutional ownership is 43.10%. The most recent insider transaction that took place on Jun 24 ’25, was worth 81,060. In this transaction 10% Owner of this company sold 231,600 shares at a rate of $0.35, taking the stock ownership to the 6,418,400 shares. Before that another transaction happened on Jun 26 ’25, when Company’s 10% Owner sold 213,257 for $0.33, making the entire transaction worth $70,375. This insider now owns 6,066,343 shares in total.
Passage Bio Inc (PASG) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 31.21% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 44.74% during the next five years compared to -1.48% drop over the previous five years of trading.
Passage Bio Inc (NASDAQ: PASG) Trading Performance Indicators
Check out the current performance indicators for Passage Bio Inc (PASG). In the past quarter, the stock posted a quick ratio of 3.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.03, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.70 in one year’s time.
Technical Analysis of Passage Bio Inc (PASG)
Compared to the last year’s volume of 0.3 million, its volume of 0.61 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 34.52%.
During the past 100 days, Passage Bio Inc’s (PASG) raw stochastic average was set at 40.59%, which indicates a significant decrease from 50.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 125.98% in the past 14 days, which was higher than the 114.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3658, while its 200-day Moving Average is $0.5328. Nevertheless, the first resistance level for the watch stands at $0.4302 in the near term. At $0.4600, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.5026. If the price goes on to break the first support level at $0.3578, it is likely to go to the next support level at $0.3152. Now, if the price goes above the second support level, the third support stands at $0.2854.
Passage Bio Inc (NASDAQ: PASG) Key Stats
There are currently 62,148K shares outstanding in the company with a market cap of 24.88 million. Presently, the company’s annual sales total 0 K according to its annual income of -64,770 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -15,410 K.
